Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review

Date: May 8, 2018
Pages: 29
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A35590384C0EN
Leaflet:

Download PDF Leaflet

Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review
Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myelodysplastic syndromes), is marketed by Otsuka in the US and by Janssen in the rest of the world. It established a strong pipeline of small molecule and molecularly-targeted drugs for treating hematologic malignancies, solid tumors and myelodysplastic syndromes. Astex Pharmaceuticals is also advancing several of its compounds into clinical trials in collaboration with Novartis, AstraZeneca, GSK and Janssen. Astex Pharmaceuticals is a subsidiary of Otsuka Pharmaceutical Co Ltd and is headquartered in Pleasanton, California, the US.

Astex Pharmaceuticals Inc Key Recent Developments

Oct 26,2017: Study to test combination therapy for breast cancer
Oct 12,2017: 10 SU2C Catalyst Clinical Trials Launched
Aug 17,2017: Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex Pharmaceuticals
Jul 25,2017: InSysBio announce renewal of agreement with ASTEX Pharmaceuticals
May 09,2017: Cancer drug design targeted by COSMIC's new 3D system

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Astex Pharmaceuticals Inc - Key Facts
Astex Pharmaceuticals Inc - Key Employees
Astex Pharmaceuticals Inc - Key Employee Biographies
Astex Pharmaceuticals Inc - Major Products and Services
Astex Pharmaceuticals Inc - History
Astex Pharmaceuticals Inc - Company Statement
Astex Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Astex Pharmaceuticals Inc - Business Description
Astex Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Astex Pharmaceuticals Inc - Strengths
Astex Pharmaceuticals Inc - Weaknesses
Astex Pharmaceuticals Inc - Opportunities
Astex Pharmaceuticals Inc - Threats
Astex Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Astex Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 26, 2017: Study to test combination therapy for breast cancer
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched
Aug 17, 2017: Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex Pharmaceuticals
Jul 25, 2017: InSysBio announce renewal of agreement with ASTEX Pharmaceuticals
May 09, 2017: Cancer drug design targeted by COSMIC's new 3D system

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Astex Pharmaceuticals Inc, Key Facts
Astex Pharmaceuticals Inc, Key Employees
Astex Pharmaceuticals Inc, Key Employee Biographies
Astex Pharmaceuticals Inc, Major Products and Services
Astex Pharmaceuticals Inc, History
Astex Pharmaceuticals Inc, Other Locations
Astex Pharmaceuticals Inc, Subsidiaries
Astex Pharmaceuticals Inc, Key Competitors
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Astex Pharmaceuticals Inc, Recent Deals Summary

LIST OF FIGURES

Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Allergan Plc
Amgen Inc
Array BioPharma Inc
Bristol-Myers Squibb Co
Exelixis Inc
Genentech Inc
Gilead Sciences Inc
Infinity Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc.
Morvus Technology Ltd
Novartis AG
OncoMed Pharmaceuticals Inc
Onyx Pharmaceuticals Inc
Sanofi
Vertex Pharmaceuticals Inc
Skip to top


Sandoz Inc - Strategic SWOT Analysis Review US$ 125.00 Jul, 2018 · 41 pages
SPI Pharma Inc - Strategic SWOT Analysis Review US$ 125.00 Jan, 2019 · 24 pages

Ask Your Question

Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: